Vor Biopharma
Tracked across 2 events · 18 articles · First seen Apr 01, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Vor Biopharma's stock experienced significant sales by a major institutional investor, leading to a decrease in its stock price and market capitalization. Despite this, analysts maintain a 'Moderate Buy' consensus.
Apr 11, 2026 · 6 articles
Business
Impact: Vor Biopharma granted stock options and restricted stock units to newly hired employees as an inducement to employment, which is a positive move for employee retention and growth.
Apr 01, 2026 · 12 articles
ERGEN INTELLIGENCE
Track Vor Biopharma live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard